- Filed
- Aug 12, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Aug 4, 2025 | 15.34M sh |
| Shares Diluted | Q2 2025 · Jun 30, 2025 | 15.4M sh |
| Shares Diluted | Q2 2025 · Jun 30, 2025 | 15.33M sh |
| Shares Diluted | Q2 2025 · Jun 30, 2024 | 15.21M sh |
| Shares Diluted | Q2 2025 · Jun 30, 2024 | 15.11M sh |
| Stock Repurchased | Q2 2025 · Jun 30, 2025 | $8.44K |
| Stock Repurchased | Q2 2025 · Jun 30, 2024 | $9.58K |
| Capex | Q2 2025 · Jun 30, 2025 | $836.55K |
| Capex | Q2 2025 · Jun 30, 2024 | $657.45K |
| Operating Cash Flow | Q2 2025 · Jun 30, 2025 | −$2.83M |
| Operating Cash Flow | Q2 2025 · Jun 30, 2024 | $1.84M |
| Cash And Equivalents | Q2 2025 · Jun 30, 2025 | $29.81M |
| Cash And Equivalents | Q2 2025 · Dec 31, 2024 | $25.05M |
| Cash And Equivalents | Q2 2025 · Jun 30, 2024 | $17.46M |
| Stockholders Equity | Q2 2025 · Jun 30, 2025 | $23.24M |
| Stockholders Equity | Q2 2025 · Dec 31, 2024 | $20.65M |
| Current Liabilities | Q2 2025 · Jun 30, 2025 | $35.51M |
| Current Liabilities | Q2 2025 · Dec 31, 2024 | $49.04M |
| Total Liabilities | Q2 2025 · Jun 30, 2025 | $49.92M |
| Total Liabilities | Q2 2025 · Dec 31, 2024 | $62.48M |
| Current Assets | Q2 2025 · Jun 30, 2025 | $63.75M |
| Current Assets | Q2 2025 · Dec 31, 2024 | $74.58M |
| Total Assets | Q2 2025 · Jun 30, 2025 | $73.18M |
| Total Assets | Q2 2025 · Dec 31, 2024 | $83.15M |
| Eps Diluted | Q2 2025 · Jun 30, 2025 | $0.01 |
| Eps Diluted | Q2 2025 · Jun 30, 2025 | $0.07 |
| Eps Diluted | Q2 2025 · Jun 30, 2024 | −$0.24 |
| Eps Diluted | Q2 2025 · Jun 30, 2024 | −$0.18 |
| Eps Basic | Q2 2025 · Jun 30, 2025 | $0.01 |
| Eps Basic | Q2 2025 · Jun 30, 2025 | $0.07 |
| Eps Basic | Q2 2025 · Jun 30, 2024 | −$0.24 |
| Eps Basic | Q2 2025 · Jun 30, 2024 | −$0.18 |
| Sga Expense | Q2 2025 · Jun 30, 2025 | $11.63M |
| Sga Expense | Q2 2025 · Jun 30, 2025 | $22.41M |
| Sga Expense restated | Q2 2025 · Jun 30, 2024 | $11.58M |
| Sga Expense restated | Q2 2025 · Jun 30, 2024 | $21.48M |
| Operating Income | Q2 2025 · Jun 30, 2025 | −$1.14M |
| Operating Income | Q2 2025 · Jun 30, 2025 | −$1.82M |
| Operating Income restated | Q2 2025 · Jun 30, 2024 | −$1.78M |
| Operating Income restated | Q2 2025 · Jun 30, 2024 | −$2.21M |
| Cost Of Revenue | Q2 2025 · Jun 30, 2025 | $2.77M |
| Cost Of Revenue | Q2 2025 · Jun 30, 2025 | $5.74M |
| Cost Of Revenue restated | Q2 2025 · Jun 30, 2024 | $2.81M |
| Cost Of Revenue restated | Q2 2025 · Jun 30, 2024 | $5.52M |